ADCAN Pharma and MS Pharma plan UAE medicine production
The proposed framework covers biosimilars, injectables and oral medicines.
- Publish date: 2026-10-20
- Category: Standards & Policy
- Original source: Emirates News Agency (WAM)
- Reading time: 1 min read
ADCAN Pharma and MS Pharma plan to localise medicines in the UAE. Their proposed framework covers manufacturing, packaging, testing and batch release for biosimilars, injectables and oral solid-dose products, including therapies for oncology, immunology and cardiovascular conditions.